EPISTEM LIMITED

Active United Kingdom

Research and experimental development on biotechnology

23 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EPISTEM LIMITED

Research and experimental development on biotechnology

Founded 25 Oct 2017 Active United Kingdom 23 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

EPISTEM 2 LIMITED 25 Oct 2017 — 13 Jun 2018
Accounts Submitted 28 Apr 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 11 Dec 2025 Next due 7 Nov 2026 5 months remaining
Net assets £-5M £874K 2025 year on year
Total assets £988K £17K 2025 year on year
Total Liabilities £6M £857K 2025 year on year
Charges 3
3 outstanding

Contact & Details

Contact

Telephone

0800 000 0000

Website

www.example.com

Full company profile for EPISTEM LIMITED (11031998), an active life sciences and medical technology company based in United Kingdom. Incorporated 25 Oct 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2018–2025)

Cash in Bank

£366.48k

Increased by £120.16k (+49%)

Net Assets

-£4.59M

Decreased by £873.88k (-24%)

Total Liabilities

£5.58M

Increased by £856.55k (+18%)

Turnover

N/A

Employees

23

Decreased by 6 (-21%)

Debt Ratio

565%

Increased by 95 (+20%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jun 2018Management Buyout

Share Capital

Share Capital

Share allotments and capital structure

20 Allotments 212,410 Shares £24k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Nov 20241,000£0£0
9 Nov 20241,000£0£0
21 Oct 202460,733£0£0
21 Oct 202420,300£0£0
21 Oct 20244,300£0£0

Officers

Officers

1 active 2 resigned
Status
Andrew MilnesDirectorEnglishEngland6229 Nov 2023Active

Shareholders

Shareholders (14)

Foresight Regional Investment Lp
67.4%
67,400
Catherine Booth
15.3%
15,300

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased

Foresight Regional Investment Lp

Unknown

Active
Notified 8 Jun 2018
Nature of Control
  • Ownership Of Shares 50 To 75 Percent

Genedrive Plc

Ceased 9 Jan 2018

Ceased

Catherine Booth

Ceased 8 Jun 2018

Ceased
Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

3 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
11 Dec 2025Confirmation StatementConfirmation statement made on 24 Oct 2025 with updates
2 Dec 2025OfficersAppointment of Ms Aude-Marine Bonavita as director on 1 Dec 2025
28 Aug 2025OfficersTermination of Andrew Milnes as director on 28 Aug 2025
13 Jun 2025ResolutionResolutions
28 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

11 Dec 2025 Confirmation Statement

Confirmation statement made on 24 Oct 2025 with updates

2 Dec 2025 Officers

Appointment of Ms Aude-Marine Bonavita as director on 1 Dec 2025

28 Aug 2025 Officers

Termination of Andrew Milnes as director on 28 Aug 2025

13 Jun 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

1 months ago on 28 Apr 2026

Confirmation statement made on 24 Oct 2025 with updates

5 months ago on 11 Dec 2025

Appointment of Ms Aude-Marine Bonavita as director on 1 Dec 2025

6 months ago on 2 Dec 2025

Termination of Andrew Milnes as director on 28 Aug 2025

9 months ago on 28 Aug 2025

Resolutions

11 months ago on 13 Jun 2025